CY1110454T1 - Γονιδιο streptomyces avermitilis που καθοριζει τον λογο αβερμεκτινων β2:β1 - Google Patents
Γονιδιο streptomyces avermitilis που καθοριζει τον λογο αβερμεκτινων β2:β1Info
- Publication number
- CY1110454T1 CY1110454T1 CY20091100467T CY091100467T CY1110454T1 CY 1110454 T1 CY1110454 T1 CY 1110454T1 CY 20091100467 T CY20091100467 T CY 20091100467T CY 091100467 T CY091100467 T CY 091100467T CY 1110454 T1 CY1110454 T1 CY 1110454T1
- Authority
- CY
- Cyprus
- Prior art keywords
- streptomyces avermitilis
- defines
- avermectin
- alter
- ratio
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
- C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
- C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Detergent Compositions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35622202P | 2002-02-12 | 2002-02-12 | |
| EP03739390A EP1476539B1 (en) | 2002-02-12 | 2003-01-31 | Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1110454T1 true CY1110454T1 (el) | 2015-04-29 |
Family
ID=27734621
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20091100467T CY1110454T1 (el) | 2002-02-12 | 2009-04-27 | Γονιδιο streptomyces avermitilis που καθοριζει τον λογο αβερμεκτινων β2:β1 |
| CY20111101193T CY1112491T1 (el) | 2002-02-12 | 2011-12-02 | Γονιδιο streptomyces avermitilis που ελεγχει την αναλογια αβερμεκτινων β2:β1 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20111101193T CY1112491T1 (el) | 2002-02-12 | 2011-12-02 | Γονιδιο streptomyces avermitilis που ελεγχει την αναλογια αβερμεκτινων β2:β1 |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US7388085B2 (https=) |
| EP (2) | EP1476539B1 (https=) |
| JP (1) | JP2005517406A (https=) |
| KR (1) | KR100718378B1 (https=) |
| CN (2) | CN1630712B (https=) |
| AR (1) | AR038405A1 (https=) |
| AT (2) | ATE426659T1 (https=) |
| AU (1) | AU2003245052B2 (https=) |
| BR (1) | BRPI0307620B8 (https=) |
| CA (1) | CA2475214C (https=) |
| CY (2) | CY1110454T1 (https=) |
| DE (1) | DE60326824D1 (https=) |
| DK (2) | DK1476539T3 (https=) |
| ES (2) | ES2373629T3 (https=) |
| IL (3) | IL162866A0 (https=) |
| ME (1) | ME00472B (https=) |
| MX (1) | MXPA04007777A (https=) |
| PL (1) | PL211693B1 (https=) |
| PT (2) | PT1476539E (https=) |
| RS (1) | RS50813B (https=) |
| RU (1) | RU2293117C2 (https=) |
| SI (2) | SI2050815T1 (https=) |
| TW (1) | TWI341330B (https=) |
| WO (1) | WO2003068955A2 (https=) |
| ZA (1) | ZA200405345B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1476539T3 (da) | 2002-02-12 | 2009-05-11 | Pfizer Prod Inc | Streptomyces avermitilis gen dirigerende forholdet af B2:B1 avermectiner |
| CN102241750B (zh) * | 2010-05-14 | 2014-05-28 | 中国科学院微生物研究所 | 一种生产阿维菌素的基因工程方法及其专用菌株 |
| CN102093997B (zh) * | 2010-12-01 | 2013-03-13 | 中国科学院上海有机化学研究所 | 一种改造除虫链霉菌产生多拉菌素的方法 |
| CN109576196B (zh) * | 2019-01-25 | 2022-01-04 | 北大方正集团有限公司 | 一种生产多拉菌素的发酵培养基及多拉菌素的生产方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE434277B (sv) | 1976-04-19 | 1984-07-16 | Merck & Co Inc | Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis |
| US4429042A (en) | 1978-09-08 | 1984-01-31 | Merck & Co., Inc. | Strain of Streptomyces for producing antiparasitic compounds |
| IN167980B (https=) | 1987-01-23 | 1991-01-19 | Pfizer | |
| US5252474A (en) | 1989-03-31 | 1993-10-12 | Merck & Co., Inc. | Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use |
| JP2761296B2 (ja) * | 1993-10-05 | 1998-06-04 | フアイザー・インコーポレイテツド | ドラメクチンの製造方法および駆虫性中間体 |
| US6117679A (en) | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| US6248579B1 (en) | 1998-02-13 | 2001-06-19 | Pfizer Inc | Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| EA003905B1 (ru) * | 1998-02-13 | 2003-10-30 | Пфайзер Продактс Инк. | Ген streptomyces avermitilis, контролирующий соотношение авермектинов b2:b1 |
| RU2156301C2 (ru) * | 1998-06-09 | 2000-09-20 | Мосин Владимир Александрович | Штамм актиномицета streptomyces avermitilis ссм 4697 - продуцент авермектинов |
| US6197591B1 (en) | 1998-09-14 | 2001-03-06 | Pfizer Inc. | Streptomyces avermitilis regulatory genes for increased avermectin production |
| CA2380872C (en) * | 1999-08-12 | 2007-11-27 | Yan Chen | Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
| MXPA02001565A (es) | 1999-08-13 | 2005-07-14 | Vertex Pharma | Inhibidores de cinasas c-jun n-terminal (jnk) y de otras cinasas proteicas. |
| DK1476539T3 (da) * | 2002-02-12 | 2009-05-11 | Pfizer Prod Inc | Streptomyces avermitilis gen dirigerende forholdet af B2:B1 avermectiner |
-
2003
- 2003-01-31 DK DK03739390T patent/DK1476539T3/da active
- 2003-01-31 RS YUP-700/04A patent/RS50813B/sr unknown
- 2003-01-31 SI SI200332087T patent/SI2050815T1/sl unknown
- 2003-01-31 AT AT03739390T patent/ATE426659T1/de active
- 2003-01-31 KR KR1020047012437A patent/KR100718378B1/ko not_active Expired - Lifetime
- 2003-01-31 SI SI200331553T patent/SI1476539T1/sl unknown
- 2003-01-31 RU RU2004124521/13A patent/RU2293117C2/ru active
- 2003-01-31 DE DE60326824T patent/DE60326824D1/de not_active Expired - Lifetime
- 2003-01-31 ME MEP-2008-730A patent/ME00472B/me unknown
- 2003-01-31 CA CA2475214A patent/CA2475214C/en not_active Expired - Lifetime
- 2003-01-31 WO PCT/IB2003/000348 patent/WO2003068955A2/en not_active Ceased
- 2003-01-31 CN CN038037416A patent/CN1630712B/zh not_active Expired - Lifetime
- 2003-01-31 BR BRPI0307620A patent/BRPI0307620B8/pt not_active IP Right Cessation
- 2003-01-31 JP JP2003568070A patent/JP2005517406A/ja active Pending
- 2003-01-31 AU AU2003245052A patent/AU2003245052B2/en not_active Expired
- 2003-01-31 MX MXPA04007777A patent/MXPA04007777A/es active IP Right Grant
- 2003-01-31 ES ES09150098T patent/ES2373629T3/es not_active Expired - Lifetime
- 2003-01-31 CN CN2011102082591A patent/CN102392028B/zh not_active Expired - Lifetime
- 2003-01-31 ES ES03739390T patent/ES2321827T3/es not_active Expired - Lifetime
- 2003-01-31 DK DK09150098.3T patent/DK2050815T3/da active
- 2003-01-31 EP EP03739390A patent/EP1476539B1/en not_active Expired - Lifetime
- 2003-01-31 PT PT03739390T patent/PT1476539E/pt unknown
- 2003-01-31 AT AT09150098T patent/ATE530645T1/de active
- 2003-01-31 IL IL16286603A patent/IL162866A0/xx unknown
- 2003-01-31 PT PT09150098T patent/PT2050815E/pt unknown
- 2003-01-31 EP EP09150098A patent/EP2050815B1/en not_active Expired - Lifetime
- 2003-01-31 PL PL371320A patent/PL211693B1/pl unknown
- 2003-02-10 AR ARP030100408A patent/AR038405A1/es active IP Right Grant
- 2003-02-10 US US10/361,376 patent/US7388085B2/en not_active Expired - Lifetime
- 2003-02-10 TW TW092102676A patent/TWI341330B/zh not_active IP Right Cessation
-
2004
- 2004-07-05 ZA ZA200405345A patent/ZA200405345B/xx unknown
- 2004-07-05 IL IL162866A patent/IL162866A/en active IP Right Grant
-
2008
- 2008-04-23 US US12/107,949 patent/US8008078B2/en not_active Expired - Fee Related
- 2008-06-22 IL IL192371A patent/IL192371A/en active IP Right Grant
-
2009
- 2009-04-27 CY CY20091100467T patent/CY1110454T1/el unknown
-
2011
- 2011-12-02 CY CY20111101193T patent/CY1112491T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1106408T1 (el) | Γονιδιωματικη αλληλουχια του χλαμυδιου της πνευμονιας (chlamydia pneymoniae) και πολυπεπτιδια, τμηματα αυτων και χρησεις αυτων, ιδιως για τη διαγνωση, την προληψη και τη θepαπευτικη αντιμετωπιση λοιμωξης | |
| DE59908447D1 (de) | Verfahren zur Herstellung von hantelförmigen DNA-Molekülen als Expressionskonstrukte | |
| CY1110454T1 (el) | Γονιδιο streptomyces avermitilis που καθοριζει τον λογο αβερμεκτινων β2:β1 | |
| CY1109797T1 (el) | Μορια πυρηνικου οξεος, κωδικοποιουντα ενζυμα, τα οποια διαθετουν δραστηριοτητα φρουκτοζυλικης τρανσφερασης, και η χρηση αυτων | |
| A. Ghomi et al. | High-throughput transposon mutagenesis in the family Enterobacteriaceae reveals core essential genes and rapid turnover of essentiality | |
| WO2021216775A3 (en) | Antigen-encoding cassettes | |
| WO2005058945A3 (de) | Genvarianten die für proteine aus dem stoffwechselweg von feinchemikalien kodieren | |
| EP1835022A4 (en) | CELL CULTURE PROCEDURE AND ITS USE | |
| ATE499440T1 (de) | Gen-targeting mit replizierenden dna-molekülen | |
| CY1105778T1 (el) | Γονιδιο του streptomyces avermitilis που κατευθυνει την αναλογια των αβepμεκτινων β2:β1 | |
| CO5070698A1 (es) | Gen de streptomyces avermitilis que dirige la relacion de avermectinas b2:b1 | |
| UY26287A1 (es) | Gen de streptomyces avermitilis que que dirige la relación de avermectinas b2:b1 | |
| BR0110128A (pt) | Mutante de bactéria láctica superprodutora de exopolissacarìdeos, utilização do mesmo e ácido nucleico codificando uma alfa-fosfoglucomutase | |
| Hardy et al. | The tRNA epitranscriptomic landscape and RNA modification enzymes in Vibrio cholerae | |
| AU2003276872A8 (en) | Methods for identifying antimicrobial compounds | |
| Zhang et al. | Prolonged Starvation Drives Epigenetic Remodeling: Insights from DNA Methylation Profiling in the Aquatic Pathogen Flavobacterium columnare | |
| Damm et al. | 6S-1 pRNA 9-mers are a prominent length species during outgrowth of Bacillus subtilis cells from extended stationary phase | |
| WO2021243218A3 (en) | Differential knockout of a heterozygous allele of samd9 | |
| Guo | Translesion synthesis and mutations: On the mutagenic properties of the two DNA lesions, 8-oxo-G and Pt-GG, and the functions of Y-family DNA polymerases and Rev3L on the bypass of each of the DNA lesions in mammalian cells | |
| WO2007044839A3 (en) | Glutamate 2,3-aminomutases and methods of use thereof | |
| Mohan et al. | genomes exhibit notable GC variation Campylobacter jejuni |